Client News
Filter by:
- Jan 4 2023 Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 & Insulin for the Treatment of Diabetes
- Jan 4 2023 Genprex Announces Selection of Preclinical Data for Oral Presentation at 16th International Conference on Advanced Technologies & Treatments for Diabetes
- Dec 28 2022 Luokung Launches "Carbon Peaking and Carbon Neutrality" Data Service with More than US$70 Million in Forecasted Revenue
- Dec 27 2022 Pingtan Marine Enterprise Announces Receipt of Nasdaq Notification Letter
- Dec 27 2022 Luokung Announces Financial Results for First Half 2022, Reports Record Revenues of Approximately $62.8 Million for the Period
- Dec 22 2022 Pingtan Marine Enterprise Announces Results of Annual General Meeting
- Dec 21 2022 Oramed Letter to Shareholders
- Dec 21 2022 NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2022
- Dec 20 2022 Ecolab Again Recognized for Sustainability Leadership by CDP and Dow Jones Sustainability World and North America Indices
- Dec 16 2022 Pingtan Marine Enterprise Responded to the Designation of Being included in the SDN List by the U.S Department of the Treasury's Office of Foreign Assets Control